DIA 2013 49th Annual Meeting
Click here to go to the previous page
FDA Enforcement Update: Advertising and Promotion
Track
:
Track 05: Regulation of Product Advertising and Marketing in an Ever-changing World
Program Code:
231
Date:
Tuesday, June 25, 2013
Time:
10:15 AM to 11:45 AM
EST
Location:
102AB
CHAIR
:
Wayne Pines, (SCHNON), President, Regulatory Services and Healthcare, APCO Worldwide Inc., United States
SPEAKER
(S):
Thomas Abrams, MBA,RPh (SPKAGY), Director, Office of Prescription Drug Promotion, CDER, FDA, United States Pamela M. Williamson, MBA,RAC (SPKNON), Senior Vice President, Global Head, Regulatory Affairs and Compliance, Genzyme Corporation, A Sanofi Company, United States
Description
FDA enforcement actions and policy guidances need to be understood by every company because they reflect FDA's priorities and concerns in regulating advertising and promotion. In this forum, an FDA professional and a representative from industry will examine the latest agency enforcement actions and policies and what they mean.
This session is a part of:
This session is a part of: